ImmunoPrecise Antibodies Ltd.

NasdaqGM:IPA Stock Report

Mkt Cap: US$82.6m

ImmunoPrecise Antibodies Past Performance

How has ImmunoPrecise Antibodies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

-36.1%

Historical annual earnings growth

Earnings and Revenue History

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies